申请人:PROFECTUS BIOSCIENCES INC
公开号:WO2010111460A1
公开(公告)日:2010-09-30
The invention relates to compounds of formulae (1) and (2), and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.
该发明涉及式(1)和式(2)的化合物,以及其药学上可接受的盐,用于治疗癌症、炎症、自身免疫性疾病、糖尿病和糖尿病并发症、感染、心血管疾病和缺血再灌注损伤。